Icon is delaying publication of its financial results while lawyers investigate if the Irish clinical trials group overstated ...

As of Thursday, February 12, ICON Public Limited Company’s ICLR share price has dipped by 43.73%, which has investors questioning if this is right time to buy.

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME ...

Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support ...

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against ...

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...

Adoption allows ICON to take full advantage of the Medidata “Data Experience,” leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts “ICON leads in risk-based ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icon ( (ICLR)) has issued an update. ICON ...

Survey points to importance of strategic engagement with investors and effective asset development strategies to optimise funding DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading ...

CRO giant Icon is partnering with Saphetor, which specializes in large-scale identification and interpretation of human genetic variants, to develop new approaches for clinical trials focused on ...